openPR Logo
Press release

Pharyngitis Market Expansion Plans Focused at Regional Revenue Share during the Period between 2017-2026

01-24-2019 01:09 PM CET | Health & Medicine

Press release from: Fact.MR

  Pharyngitis also known as pharynx is inflammation of the back of the throat resulting in a sore throat. It may be bacterial or viral, the most common bacteria that infect human throat is Group A Streptococcus. Various market players are working on developing rapid diagnostic testing solutions for the fast detection of infection to provide treatment at an early stage. According to the medical professionals, around 50% of a sore throat or pharyngitis is caused by viral infection, while around 15-20% is caused by bacterial infection. Hence, throat lozenges are also being prescribed for people suffering from pharyngitis and it also offers temporary relief from cough and cold, which the most common cause of sore throat. As per Randomized Controlled Trial (RCT) published recently in Canadian Medical Association Journal, found that probiotics and xylitol chewing gum have no effect on a sore throat or pharyngitis symptoms. Hence, drug manufacturers are conducting research to develop new drugs to fight sore throat without causing any side-effects. Pharyngitis  Market to experience sluggish growth. Towards 2026 end, the global market for pharyngitis is projected to bring in US$ 1,679.0 million revenue.

Request Sample:

https://www.factmr.com/connectus/sample?flag=S&rep_id=361

Beta Lactams to Emerge as the Most-Preferred Drug Class

Compared to the various drug class, beta lactams is likely to emerge as one of the most preferred drug class between 2017 and 2026. Beta lactams is projected to bring in nearly US$ 500 million revenue by 2026 end. Beta-lactams include cephalosporins and penicillins. These drugs are active against many harmful organisms. Moreover, the recent development of broad-spectrum beta-lactams antibiotics active against gram-negative organisms has increased their use.

For More Information Raise Enquiry Here:

https://www.factmr.com/connectus/sample?flag=AE&rep_id=361

Retail Pharmacies and Drug Stores to Emerge as the Biggest Distribution Channel

Retail pharmacies and drug stores are likely to gain maximum revenue share. By 2026 end, retail pharmacies and drug stores are projected to bring in nearly US$ 700 million revenue. A sore throat is very common, pharmacists can assess specific symptoms as described by patients and based on it can suggest Over the Counter (OTC) drug that available at retail pharmacies and drug stores. One of the most commonly used OTC products for treating sore throat is lozenges. Moreover, pharmaceutical companies are also introducing new products that can offer rapid relief in pain.

Pharyngitis Market Table of Content

Global Economic Outlook
 

Global Pharyngitis Market - Executive Summary
 

Global Pharyngitis Market Overview
3.1. Introduction

       3.1.1. Global Pharyngitis Market Taxonomy

       3.1.2. Global Pharyngitis Market Definition

3.2. Global Pharyngitis Market Size (US$ Mn) and Forecast, 2012-2026

       3.2.1. Global Pharyngitis Market Y-o-Y Growth

3.3. Global Pharyngitis Market Dynamics

3.4. Supply Chain

3.5. Cost Structure

3.6. Pricing Analysis

3.7. Drug Pipeline Assessment

3.8. Product Life Cycle

3.9. PEST Analysis

And Continue………

Browse Full Report on Pharyngitis Needle Market with TOC-

https://www.factmr.com/report/361/pharyngitis-market

The report has also profiled leading players in the global market for pharyngitis, which will remain active through 2026. These include companies such as GlaxoSmithKline PLC, Pfizer Inc., Novartis AG, Zambon Group SpA, and BioStar Pharmaceuticals, Inc.

 

To Buy Pharyngitis Market Report

https://www.factmr.com/checkout/361/S

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us

Fact.MR

11140 Rockville Pike

Suite 400

Rockville, MD 20852

United States

Email: sales@factmr.com

Web: https://www.factmr.com/

Read Industry News at - https://www.industrynewsanalysis.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pharyngitis Market Expansion Plans Focused at Regional Revenue Share during the Period between 2017-2026 here

News-ID: 1530035 • Views:

More Releases from Fact.MR

Triple Negative Breast Cancer Treatment Market is Growing at a CAGR of 4.6% by 2034 | Key players: Pfizer Inc., F. Hoffman-La Roche Ltd., Sanofi S.A., and Seattle Genetics, and Genentech.
10-03-2025 | Health & Medicine
Fact.MR
Triple Negative Breast Cancer Treatment Market is Growing at a CAGR of 4.6% by 2 …
Fact.MR today unveiled its latest report on the Triple Negative Breast Cancer Treatment Market, projecting steady yet impactful growth amid rising global breast cancer incidences and a push for innovative therapies targeting this aggressive subtype. Valued at USD 670.5 million in 2024, the global market is forecasted to expand at a compound annual growth rate (CAGR) of 4.6%, reaching USD 1.04 billion by 2034. This expansion underscores the urgent need
Pulmonary Fibrosis Treatment Market: U.S. to Grow to US$ 4.06 Billion by 2034, Led by Roche, Boehringer Ingelheim & Others
10-03-2025 | Health & Medicine
Fact.MR
Pulmonary Fibrosis Treatment Market: U.S. to Grow to US$ 4.06 Billion by 2034, L …
The global pulmonary fibrosis treatment market is poised for steady expansion, with its valuation projected to grow from USD 3,210 million in 2025 to USD 5,890 million by 2035. This growth reflects a compound annual growth rate (CAGR) of 6.2% over the forecast period from 2025 to 2035. The surge is primarily driven by the increasing prevalence of idiopathic pulmonary fibrosis (IPF), rising awareness of early diagnosis, and advancements in
Spices and Seasonings Market is Projected to Reach USD 23.6 Billion by 2035 | McCormick & Company, Associated British Foods, Olam International, Sensient Technologies, Kerry Group
10-03-2025 | Food & Beverage
Fact.MR
Spices and Seasonings Market is Projected to Reach USD 23.6 Billion by 2035 | Mc …
The global spices and seasonings market is set for significant growth, projected to expand from USD 14.5 billion in 2025 to USD 23.6 billion by 2035, achieving an absolute increase of USD 8.3 billion and a 57.2% overall growth. This trajectory reflects a compound annual growth rate (CAGR) of 5.0% over the forecast period from 2025 to 2035, representing a 1.57X market size increase. The expansion is driven by rising
Accounting Services Market: U.S. to Grow to US$ 640.73 Billion by 2034 at 10.3% CAGR, Supported by PwC, EY, Deloitte & KPMG
Accounting Services Market: U.S. to Grow to US$ 640.73 Billion by 2034 at 10.3% …
The global accounting services market is positioned for substantial growth, with its valuation projected to increase from USD 650 billion in 2025 to USD 1,250 billion by 2035. This expansion reflects a compound annual growth rate (CAGR) of 6.7% over the forecast period from 2025 to 2035. The market's surge is driven by the increasing complexity of financial regulations, the digital transformation of businesses, and the rising demand for outsourced

All 5 Releases


More Releases for Pharyngitis

Increasing Strep Throat Transmission Fueling Growth In The Pharyngitis Treatment …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts What Is the Expected CAGR for the Pharyngitis Treatment Market Through 2025? The market for pharyngitis treatment has seen consistent growth over the past few years. The predicted expansion is from $2.27 billion in 2024 to $2.37 billion in 2025, with a compound annual growth rate (CAGR) of 4.5%.
Increasing Strep Throat Transmission Fueling Growth In The Pharyngitis Treatment …
The Pharyngitis Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Pharyngitis Treatment Market Size and Projected Growth Rate? In recent times, there has been a consistent increase in the size of the pharyngitis treatment market. It is projected to expand from $2.27
Revolutionizing Relief: Contemporary Approaches to Pharyngitis Treatment
Pharyngitis is a disorder that is typically characterized by the inflammation of the pharynx. It is most commonly known as sore throat. It causes pain, discomfort and scratchiness in the throat that further leads to difficulty in swallowing. The most common cause of its occurrence is due to viral infections such as common cold, influenza and others. The early treatment is essential to relive the pain. The typical symptoms includes
01-22-2021 | Health & Medicine
Fact.MR
Pharyngitis Market Future Forecast Indicates Impressive Growth Rate
Pharyngitis also known as pharynx is inflammation of the back of the throat resulting in a sore throat. It may be bacterial or viral, the most common bacteria that infect human throat is Group A Streptococcus. Various market players are working on developing rapid diagnostic testing solutions for the fast detection of infection to provide treatment at an early stage. According to the medical professionals, around 50% of a sore
Pharyngitis Therapeutics Market - Regional Insights
Pharyngitis treatment is majorly based on the symptoms, depending the cause of pharyngitis for example, bacterial, fungal, and herpes simplex infections. The common symptoms of pharyngitis include sneezing, runny nose, headache, cough, fatigue, body aches, chills, and fever. Additionally, strep throat condition also occurs, which may lead to difficulty in swallowing, loss of appetite, nausea, fever, loss of taste, and swollen lymph nodes. Pain medication such as NSAIDs and
Researchers Discover Potential of Pharyngitis Therapeutics Market
Pharyngitis Therapeutics Market report 2018-2026 focuses on the major drivers and restraints for the key players. These research report also provides granular analysis of the market share, segmentation, revenue forecasts and geographic regions of the market. The Pharyngitis Therapeutics Market research report is a professional and in-depth study on the current state of Pharyngitis Therapeutics Industry. The Pharyngitis Therapeutics Market research report covers the present scenario and the growth prospects of